OrbiMed’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
Other funds holding VERA
KCM
OrbiMed's VERA Position: Q3 2026 in Review
OrbiMed sold out of Vera Therapeutics (VERA) in Q3 2026, closing a stake of 369,596 shares — an estimated $15.9M sold.
OrbiMed first reported a position in VERA in Q1 2023 and held it in 12 quarters. The position peaked at $31.4M in Q4 2024. 224 funds tracked by Wall St. Rank hold VERA as of Q3 2026.
- OrbiMed reported no remaining Vera Therapeutics position as of Q3 2026 after selling out during the quarter.
- OrbiMed sold 369,596 Vera Therapeutics shares in Q3 2026, an estimated $15.9M.
- OrbiMed first reported a position in Vera Therapeutics in Q1 2023 and held it in 12 quarters.
- OrbiMed's Vera Therapeutics position peaked at $31.4M in Q4 2024.
- 224 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.
Based on OrbiMed's 13F filing for Q3 2026, filed 16 Nov 2026.